Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |